Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 265,300 | 167,900 | 172,700 | 206,600 | 199,600 |
| Marketable Securities | N/A | N/A | N/A | N/A | 35,600 |
| Receivables | 1,222,400 | 1,145,400 | 1,124,900 | 1,195,400 | 1,100,800 |
| Inventories | 718,300 | 671,700 | 677,000 | 686,600 | 783,700 |
| Other current assets | 290,500 | 243,100 | 228,800 | 258,600 | 235,100 |
| TOTAL | $2,496,500 | $2,228,100 | $2,203,400 | $2,347,200 | $2,354,800 |
| Non-Current Assets | |||||
| PPE Net | 2,542,200 | 2,491,300 | 2,513,500 | 2,528,300 | 2,551,100 |
| Intangibles | 1,897,000 | 1,791,300 | 1,904,000 | 0 | 0 |
| Other Non-Current Assets | 543,100 | 576,500 | 363,900 | 2,376,800 | 2,517,200 |
| TOTAL | $4,982,300 | $4,859,100 | $4,781,400 | $4,905,100 | $5,068,300 |
| Total Assets | $7,478,800 | $7,087,200 | $6,984,800 | $7,252,300 | $7,423,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 314,400 | 298,500 | 325,500 | 320,200 | 338,900 |
| Accounts payable and accrued liabilities | 753,600 | 728,300 | 678,100 | 738,900 | 764,800 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 845,900 |
| TOTAL | $2,445,400 | $2,148,700 | $2,123,500 | $2,244,100 | $2,273,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,684,900 | 3,210,800 | 2,812,000 | 2,536,900 | 2,243,300 |
| aiOther Non-Current Liabilities | 1,005,400 | 888,600 | 722,300 | 555,900 | 674,000 |
| TOTAL | $4,146,300 | $4,588,200 | $4,014,900 | $3,540,100 | $3,315,900 |
| Total Liabilities | $6,591,700 | $6,736,900 | $6,138,400 | $5,784,200 | $5,589,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,065,220 | 1,074,543 | 1,097,948 | N/A | N/A |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 7,433,000 | 6,518,500 | 5,643,600 | 4,893,700 | 4,212,300 |
| Other shareholders' equity | -2,197,900 | -2,206,000 | -1,836,100 | -1,614,500 | -1,118,700 |
| TOTAL | $887,100 | $350,300 | $846,400 | $1,468,100 | $1,833,700 |
| Total Liabilities And Equity | $7,478,800 | $7,087,200 | $6,984,800 | $7,252,300 | $7,423,100 |